Hypoxia-Inducible Factors in Rheumatoid Arthritis: Central Pathogenic Roles and Therapeutic Opportunities.

Area of Science:

• Rheumatology
• Molecular Biology
• Immunology

Background:

• Rheumatoid arthritis (RA) joints exhibit a hypoxic microenvironment.
• Hypoxia-inducible factors (HIFs) are activated in RA synovium, correlating with disease activity.
• HIF signaling links hypoxia to RA pathogenesis, including inflammation and joint destruction.

Purpose of the Study:

• To review the role of HIF signaling in RA pathogenesis.
• To explore HIF's effects on immune cells, metabolism, angiogenesis, and joint damage.
• To discuss therapeutic strategies and translational challenges for HIF-targeted RA treatments.

Main Methods:

• Literature review of current evidence on HIF in RA.
• Analysis of HIF's regulatory effects on cellular processes in RA.
• Discussion of emerging therapeutic approaches and clinical translation.

Main Results:

• Both HIF-1α and HIF-2α accumulate in RA synovium, affecting various cell types.
• HIF-1α regulates inflammation and metabolism; HIF-2α drives cartilage degradation and joint damage.
• HIF signaling is a central mediator of RA pathology.

Conclusions:

• HIF signaling plays a critical role in RA pathogenesis through isoform-specific functions.
• Targeting HIF offers potential therapeutic avenues for RA.
• Further research is needed to address challenges in isoform selectivity, drug delivery, and patient stratification for HIF-targeted therapies.